Biocon trades in green on the bourses

04 Jun 2018 Evaluate

Biocon is currently trading at Rs. 657.50, up by 8.65 points or 1.33% from its previous closing of Rs. 648.85 on the BSE.

The scrip opened at Rs. 652.00 and has touched a high and low of Rs. 660.35 and Rs. 642.00 respectively. So far 632760 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 682.60 on 30-May-2018 and a 52 week low of Rs. 305.00 on 10-Jul-2017.

Last one week high and low of the scrip stood at Rs. 682.60 and Rs. 641.10 respectively. The current market cap of the company is Rs. 39000.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.92% and 18.41% respectively.

Biocon and Mylan N.V. will present 48 week results from the HERITAGE study at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 1-5. The HERITAGE study compared Ogivri, the first biosimilar for Herceptin approved in the US, to the reference product in patients with metastatic breast cancer in combination with taxanes for the first 24 weeks and then as a monotherapy until progression. Data obtained after 48 weeks of treatment will be included as part of the Clinical Science Symposium titled, ‘The Arrival of Biosimilars,’ on June 4.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

364.20 -2.20 (-0.60%)
27-Jan-2026 12:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.00
Dr. Reddys Lab 1242.60
Cipla 1308.45
Zydus Lifesciences 891.95
Lupin 2143.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×